

EDUCATION AND TRAINING
Ph.D., Hershey Medical Center, Pennsylvania State University, Hershey, PA
Fellowship, Hershey Medical Center, Department of Physiology
|
|
John F. Oram, Ph.D.
Research Professor of Medicine
Division of Metabolism, Endocrinology and Nutrition
OFFICE ADDRESS
University of Washington Medical Center
1959 NE Pacific Street
UW Mailbox 356426
Seattle, WA 98195-6426
CURRENT RESEARCH INTERESTS
Studies of biochemical mechanisms by which high density lipoprotein (HDL) removes
cellular cholesterol and phospholipids and protect against heart
disease. Characterization of cellular pathways involved in
cholesterol trafficking and their regulation by lipoproteins, cytokines, and hormones.
Identification and characterization of signaling molecules involved in modulating
cholesterol trafficking. Identification of genes and gene products involved in
HDL-mediated removal of cellular lipids. Studies of the molecular
and cellular properties of ABCA1 and ABCG1, membrane transporters that
mediate
secretion of excess cellular cholesterol. Characterization of the properties of HDL apolipoproteins responsible for
cellular interactions that facilitate lipid removal. Studies of the effects of diabetes on
the properties and activity of ABCA1, ABCG1, and cellular cholesterol
trafficking.
REPRESENTATIVE PUBLICATIONS
Francis GA, Knopp RH, and Oram JF: Defective removal of cellular cholesterol and
phospholipids by apolipoprotein A-I in Tangier Disease. J Clin Invest 96:78-87, 1995.
Lawn RM, Wade DP, Garvin MR, Wang X, Schwartz K, Porter JG, Seilhamer JJ,
Vaughan AM, and Oram JF: The Tangier disease gene product ABC1
controls the cellular apolipoprotein-mediated lipid removal
pathway. J Clin Invest 104:R25-R31, 1999.
Oram JF, Heinecke JW: ATP-binding cassette transporter A1: a cell cholesterol exporter that protects
against cardiovascular disease. Physiol Rev 85:1343-72,
2005.
Oram JF, Vaughan AM: ATP-Binding cassette cholesterol transporters and cardiovascular disease.
Circ Res 99:1031-43, 2006.
Vaughan AM, Oram JF: ABCA1 and ABCG1 or ABCG4 act sequentially to remove cellular cholesterol and
generate cholesterol-rich HDL. J Lipid Res 47:2433-43, 2006.
Tang C, Vaughan AM, Anantharamaiah GM, Oram JF: Janus kinase 2 modulates the lipid-removing but not protein-stabilizing
interactions of amphipathic helices with ABCA1. J Lipid Res
47:107-14, 2006.
Wang Y, Oram JF: Unsaturated fatty acids phosphorylate and destabilize ABCA1 through a protein
kinase C delta pathway.
J Lipid Res 48:1062-8, 2007.
|